1Cork Cancer Research Centre, Mercy University Hospital and Leslie C. Quick Jnr. Laboratory, University College Cork, 2Department of Computer Science, University College Cork
This article is a part ofJoVE Clinical and Translational Medicine. If you think this article would be useful for your research, please recommend JoVE to your institution's librarian.Recommend JoVE to Your Librarian
Current Access Through Your IP Address
Current Access Through Your Registered Email Address
Rajendran, S., Salwa, S., Gao, X., Tabirca, S., O'Hanlon, D., O'Sullivan, G. C., et al. Ex Vivo Culture of Patient Tissue & Examination of Gene Delivery. J. Vis. Exp. (46), e2378, doi:10.3791/2378 (2010).
This video describes the use of patient tissue as an ex vivo model for the study of gene delivery. Fresh patient tissue obtained at the time of surgery is sliced and maintained in culture. The ex vivo model system allows for the physical delivery of genes into intact patient tissue and gene expression is analysed by bioluminescence imaging using the IVIS detection system. The bioluminescent detection system demonstrates rapid and accurate quantification of gene expression within individual slices without the need for tissue sacrifice. This slice tissue culture system may be used in a variety of tissue types including normal and malignant tissue and allows us to study the effects of the heterogeneous nature of intact tissue and the high degree of variability between individual patients. This model system could be used in certain situations as an alternative to animal models and as a complementary preclinical mode prior to entering clinical trial.
Preparation of Media and Reagents
I. Tissue collection and storage
Approval for patient tissue collection was obtained from the Clinical Research Ethics Committee of the Cork Teaching Hospitals and informed consent was obtained from the patients the day before surgery. Liver tissue was obtained from patients undergoing partial hepatectomy for malignant disease.
II. Tissue slice preparation and culture
Slicing was performed using a vibratome (Leica, Germany). The tissue slicing system was used according to the manufacturer's instructions. Tissue slice preparation was performed under a sterile hood using instruments cleaned with 70% 2-propanol. Slice thickness is set at 2000 microns and cut using a reciprocating blade at 22-26 rpm.
III. Gene delivery to tissue slices
IV. Analysis of gene expression by bioluminescent analysis
V. Representative Results
Figure 1. Bioluminescent imaging of patient liver slices using IVIS detection system.
We describe an ex vivo patient tissue culture method and bioluminescent detection system for the assessment of gene delivery within non-fixed human tissue. The method offers a simple and reproducible way of culturing tissue slices. It has significant potential as it allows the study of gene delivery into intact human tissue, the analysis of gene delivery into a variety of human tissue including malignant tissue and can provide important information concerning the effects of the high degree of variability between individual patients with respect to gene uptake. Different cancer types may have varying influences on the efficacy of the different stages of successful transgene expression in cells, involving DNA uptake and subsequent transcription and translation. These steps are outlined in the video animation, using viral vector as an example. The bioluminescent detection system demonstrates rapid and accurate quantification of gene expression within individual slices without the need for tissue sacrifice. For replication incompetent vectors, such as employed in this study, luminescence is directly related to gene expression by cells.
This model system will provide valuable information regarding gene delivery to patient tissue prior to entering clinical trial.
No conflicts of interest declared.
This work was funded through the Cork South Infirmary Victoria University Hospital Breast fund, the Irish Cancer Society (CRI07TAN) and the Cork Cancer Research Centre. Replication incompetent recombinant Adenovirus 5 particles under the transcriptional control of the CMV promoter was a kind gift from Prof. Andrew Baker, University of Glasgow.
|Firefly Luciferin||Biosynth International, Inc|
|Dermabond||Johnson & Johnson|
|Vibrotome||Leica Microsystems||VT 1000 A|